We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Community infrastructure levy notice under Regulation 117, 118 or 119 decisions issued from 1 January 2023
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Browse cases data for specific areas within the UK.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Guidance on choosing evaluation study types and methods.
How to use a factorial randomised controlled trial to evaluate your digital health product.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
How to use a cost utility analysis to evaluate your digital health product.
Compare different evaluation approaches and choose an appropriate method.
Blogs where government organisations talk about their work and share information and ideas.
How to use usability testing to evaluate your digital health product.
Help your team understand why they need to meet the website and mobile app accessibility regulations.
How to use interviews to evaluate your digital health product.
The official UK government website for data and insights on COVID-19.
How to use routinely collected data to evaluate your digital health product.
The CMA is investigating Google’s conduct in relation to Google’s distribution of apps on Android devices in the UK, in particular Google Play’s rules which oblige certain app developers to use Google Play’s own billing system for in-app purchases.
How to use feedback from marketplace reviews to evaluate your digital health product.
How to create a model of how your digital health product works and choose measures for your evaluation.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.